March 25, 2021

Movano Inc. Appoints Medtech Industry Veteran John Mastrototaro, PhD, as CEO

Read More 9
March 25, 2021

Movano Inc. Announces Closing of Initial Public Offering and Exercise of Over-Allotment Option

Read More 9
March 23, 2021

Movano Inc. Prices $42.5 Million Public Offering of Common Stock

Read More 9
September 24, 2020

GLOBALFOUNDRIES and Movano Inc. Partner to Advance Needle-Free Continuous Glucose Monitoring Technology

Read More 9
August 29, 2020

Movano Inc. Closes Bridge Financing Round at $12.5M

Read More 9
July 14, 2020

Movano Inc. Exits Stealth Mode and Secures $10M in Additional Funding to Transform Glucose Monitoring with Non-Invasive Technology

Read More 9